Introduction of the FIP-WHO technical guidelines: Points to consider in the provision by health-care professionals of children-specific preparations that are not available as authorized products
- At: 2016 FIP Congress in Buenos Aires (Argentina)
- Type: Presentation
- By: KOPP, Sabine (World Health Organization, Medicines Quality Assurance, Signy, Switzerland)
- Co-author(s): Sabine Kopp:Medicines Quality Assurance,World Health Organization,Geneva,Switzerland
Paediatric patients should have access to authorized, age-appropriate preparations of medicines that can be administered safely and effectively. It is recognized that many of such preparations are not always available. In the context of paediatric pharmacy practice, FIP and WHO jointly worked on the development of a guidance document which has,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.